Great to see they are upping the ante on the corporate presentations too. Nice and steady. Still has room to grow but a vast improvement in the right direction. This has all the hallmarks of a nice and steady burn, continuous improvement. Not the hype, hoorah, up and down, pump and dump style of most others in this position.
Goes to show you too what you can do when you got your finances sorted, both capital and early earnings to generate cashflow to assist in organic growth. Lets management focus on actually extracting, processing and selling a product, as opposed to focusing on the SP. It will, IMO, 100% look after itself.
I am getting more comfortable every week - and I'm sure it's not exuberance. It is as wombat to aptly put it yesterday, it is one de-risking step after the next - all making ADN look even more promising!
- Forums
- ASX - By Stock
- ADN
- Ann: Share Cafe Webinar and Presentation
ADN
andromeda metals limited
Add to My Watchlist
0.00%
!
1.2¢

Ann: Share Cafe Webinar and Presentation, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.78M |
Open | High | Low | Value | Volume |
1.2¢ | 1.3¢ | 1.2¢ | $9.35K | 769.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
39 | 19173454 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 5407281 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 16998454 | 0.012 |
20 | 8254133 | 0.011 |
34 | 18868777 | 0.010 |
6 | 7846464 | 0.009 |
7 | 7549375 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 4412468 | 13 |
0.014 | 7210036 | 12 |
0.015 | 4915369 | 12 |
0.016 | 3727000 | 6 |
0.017 | 554297 | 5 |
Last trade - 16.11pm 04/07/2025 (20 minute delay) ? |
Featured News
ADN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online